Analysts have set 12-month price targets for Ocular Therapeutix, revealing an average target of $15.71, a high estimate of $19.00, and a low estimate of $14.00.

Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -27.59% and 37.36%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

BEDFORD, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a fully-integrated biopharmaceutical company committed to redefining the retina experience ...

No writing assistance was utilized in the production of this manuscript. Cite this: Update on Ocular Behcet's Disease - Medscape - Dec 01, 2007.

Ocular surface disease indicators A patient who is diagnosed with OSD often experiences irritations such as dry eye, redness, excessive tearing, a sandy/gritty feeling, burning/itching, or a ...

The ciliary body was, however, hypoplastic, and the iris showed a posterior synechia between the central margin and the adjacent anterolateral portion of the lens capsule (Fig. 2); in one area ...

Ocular Therapeutix obtained FDA support to use the phase 3 SOL-R trial as the next step in the regulatory process for Axpaxli, according to a press release. The FDA agreed in a Type C written ...

The impact of Steven-Johnson Syndrome on the eyes is particularly prominent, resulting in severe eye pain, light sensitivity, vision loss, and, in some cases, blindness.

It can lead to reduced visual acuity — which is the eyes’ ability to distinguish shapes and object details — and color vision impairment. The visual acuity of people with ocular albinism ...

Eye infections are an important cause of vision loss worldwide. Patients with these infections are commonly seen by primary care providers, internists, emergency medicine specialists, hospitalists ...

Four indicated retinal vasculitis. After therapy, ocular manifestations of syphilis infection typically improved, although 1 eye presented moderate OCV and another had posterior synechia. Patients did ...